Skip to content

Serotonin research published in 2009

25 studies whose primary subject is serotonin were published in 2009, down from 34 in 2008. Newest first. Back to the serotonin overview

Studies

Peduncular hallucinosis: a polysomnographic and spect study of a patient and efficacy of serotonergic therapy.

Sleep Medicine December 2009 Roberto Vetrugno, Alessandra Vella, Mario Mascalchi et al.

Peduncular hallucinosis (PH) consists of formed and coloured visual images, which the patient knows are unreal; it is often associated with lesions of the pons, midbrain and diencephalon. A 72-year-old man had noted the sudden onset of visual hallucinations one year before, specifying the time and body position in a 4-week, 24-h diary. Thereafter, he underwent video-polysomnography (VPSG),...

Brain serotonin, psychoactive drugs, and effects on reproduction.

Central nervous system agents in medicinal chemistry December 1, 2009 María Elena Ayala

Serotonin, a biogenic amine, is present in significant amounts in many structures of the CNS. It is involved in regulation of a wide variety of physiological functions, such as sensory and motor functions, memory, mood, and secretion of hormones including reproductive hormones. It has also been implicated in the etiology of a range of psychiatric disorders such as anxiety, depression, and...

Effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity

Journal of Neurochemistry November 30, 2009 Dominik K. Biezonski, Jerrold S. Meyer 47 citations

J. Neurochem. (2009) 112 , 951–962. Abstract 3,4‐Methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) is a popular recreational drug used worldwide. This study aimed to determine the effects of this compound on the expression of nerve terminal serotonergic markers in rats. Experiment 1 investigated MDMA‐induced changes in levels of the serotonin transporter (SERT) and the vesicular monoamine...

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor

Psychopharmacology November 24, 2009 Adam L. Halberstadt, Mark A. Geyer 76 citations

RATIONALE: Compounds that activate the 5-HT(2A) receptor, such as lysergic acid diethylamide (LSD), act as hallucinogens in humans. One notable exception is the LSD congener lisuride, which does not have hallucinogenic effects in humans even though it is a potent 5-HT(2A) agonist. LSD and other hallucinogens have been shown to disrupt prepulse inhibition (PPI), an operational measure of...

Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice

PLoS One November 20, 2009 Stéphane Doly, Jesus Bertran‐gonzalez, Jacques Callebert et al. 80 citations

The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and serotonin transporters to produce efflux of dopamine and serotonin, respectively, in regions of the brain that have been implicated in reward. However, the role of serotonin/dopamine interactions in the behavioral effects of MDMA remains unclear. We previously showed that MDMA-induced locomotion,...

Rapid modulation of spine morphology by the 5-HT 2A serotonin receptor through kalirin-7 signaling

Proceedings of the National Academy of Sciences November 4, 2009 Kelly A. Jones, Deepak P. Srivastava, John Allen et al. 215 citations

The 5-HT(2A) serotonin receptor is the most abundant serotonin receptor subtype in the cortex and is predominantly expressed in pyramidal neurons. The 5-HT(2A) receptor is a target of several hallucinogens, antipsychotics, anxiolytics, and antidepressants, and it has been associated with several psychiatric disorders, conditions that are also associated with aberrations in dendritic spine...

DOI: 10.1073/pnas.0905884106 (opens in new tab) Serotonin Dendritic spine Cell biology Postsynaptic potential +3

Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.

British Journal of Pharmacology November 2009 P Quérée, S Peters, T Sharp

Recent experiments using non-selective 5-hydroxytryptamine (5-HT)(2C) receptor agonists including WAY 161503 suggested that midbrain 5-HT neurones are under the inhibitory control of 5-HT(2C) receptors, acting via neighbouring gamma-aminobutyric acid (GABA) neurones. The present study extended this pharmacological characterization by comparing the actions of WAY 161503 with the 5-HT(2C)...

Serotonin 5- Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases

Cardiovascular Psychiatry and Neurology October 13, 2009 Charles D. Nichols 43 citations

There are high levels of comorbidity between neuropsychiatric and cardiovascular disorders. A key molecule central to both cognitive and cardiovascular function is the molecule serotonin. In the brain, serotonin modulates neuronal activity and is actively involved in mediating many cognitive functions and behaviors. In the periphery, serotonin is involved in vasoconstriction, inflammation, and...

DOI: 10.1155/2009/475108 (opens in new tab) Full text (opens in new tab) Serotonin Schizophrenia object-oriented programming Comorbidity Cognition +2

Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.

Drug Metabolism and Disposition October 2009 Melanie Mueller, Jie Yuan, Anne Felim et al.

The mechanism by which the recreational drug (+/-)-3,4-methylenedioxymethamphetamine (MDMA) destroys brain serotonin (5-HT) axon terminals is not understood. Recent studies have implicated MDMA metabolites, but their precise role remains unclear. To further evaluate the relative importance of metabolites versus the parent compound in neurotoxicity, we explored the relationship between...

MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.

Behavioral Neuroscience October 1, 2009 Jacobi I. Cunningham, Jamie Raudensky, John Tonkiss et al. 27 citations

3,4-Methylenedioxymethamphetamine (MDMA) is a drug of abuse worldwide and a selective serotonin (5-HT) neurotoxin. An important factor in the risk of drug abuse and relapse is stress. Although multiple parallels exist between MDMA abuse and stress, including effects on 5-HTergic neurotransmission, few studies have investigated the consequences of combined exposure to MDMA and chronic stress....

DOI: 10.1037/a0016716 (opens in new tab) MDMA Serotonergic Serotonin transporter Hippocampus +3

Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines

Dialogues in Clinical Neuroscience September 30, 2009 Euphrosyne Gouzoulis‐mayfrank, Jörg Daumann 115 citations

Ecstasy (MDMA, 3,4-methylendioxymethamphetamine) and the stimulants methamphetamine (METH, speed) and amphetamine are popular drugs among young people, particularly in the dance scene. When given in high doses both MDMA and the stimulant amphetamines are clearly neurotoxic in laboratory animals. MDMA causes selective and persistent lesions of central serotonergic nerve terminals, whereas...

MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats.

European Journal of Pharmacology September 15, 2009 Alinde E Wallinga, Anna M Ten Voorde, Sietse F De Boer et al.

Ecstasy or 3,4-methylenedioxymethamphetamine (MDMA) is a frequently (ab)used recreational drug for its acute euphoric effects but on the long-term may cause neurotoxic damage to serotonin (5-hydroxytryptamine; 5-HT) nerve endings in the brain. Since decreased brain 5-HT function has been strongly associated with several impulse control disorders like hostility and violent aggression, ecstasy...

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

Journal of Neural Transmission September 12, 2009 Nicholas V. Cozzi, Anupama Gopalakrishnan, Lyndsey L. Anderson et al. 144 citations

N,N-dimethyltryptamine (DMT) is a potent plant hallucinogen that has also been found in human tissues. When ingested, DMT and related N,N-dialkyltryptamines produce an intense hallucinogenic state. Behavioral effects are mediated through various neurochemical mechanisms including activity at sigma-1 and serotonin receptors, modification of monoamine uptake and release, and competition for...

DOI: 10.1007/s00702-009-0308-8 (opens in new tab) DMT 5-HT Hallucinogens psychedelics Psychoactive compounds +19

5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition.

Pharmacology, Biochemistry, and Behavior September 1, 2009 Vikas Duvvuri, Victoria B Risbrough, Walter H. Kaye et al. 7 citations

We propose a translational approach to the study of anorexia nervosa (AN) based on our human subject studies where there are characteristic elevations in 5-HT(1A) receptor binding, associated harm avoidance behaviors, reduced impulsivity, and comorbid anxiety disorders. Towards this goal, the hyponeophagia assay was implemented whereby food-deprived mice show increased latency to begin feeding...

DOI: 10.1016/j.pbb.2009.05.014 (opens in new tab) Full text (opens in new tab) Anxiety stress Psychological distress Apprehension Food intake +8

Chemical Interactions with Pyramidal Neurons in Layer 5 of the Cerebral Cortex: Control of Pain and Anxiety

Current Medicinal Chemistry August 20, 2009 John S. Adams 7 citations

Pyramidal neurons in layer 5 of the cerebral cortex are involved in learning and memory and have complex connections with other neurons through a very large array of dendrites. These dendrites can switch between long term depression and long term potentiation depending on global summation of various inputs. The plasticity of the input into pyramidal neurons makes the neuronal output variable....

5-HT_2A and 5-HT_2C Receptors Exert Opposing Effects on Locomotor Activity in Mice

Neuropsychopharmacology July 1, 2009 Adam L. Halberstadt, Iris Van der Heijden, Michael A Ruderman et al.

Although it is well established that hallucinogens act as 5-HT_2A and 5-HT_2C receptor agonists, little is known about the relative contributions of 5-HT_2A and 5-HT_2C receptors to the acute behavioral effects of these drugs. The behavioral pattern monitor was used to characterize the effects of the hallucinogen 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on locomotor and investigatory...

PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors

Journal of Neuroscience June 3, 2009 Atheir I. Abbas, Prem N. Yadav, Wei-Dong Yao et al. 131 citations

Here, we report that postsynaptic density protein of 95 kDa (PSD-95), a postsynaptic density scaffolding protein, classically conceptualized as being essential for the regulation of ionotropic glutamatergic signaling at the postsynaptic membrane, plays an unanticipated and essential role in mediating the actions of hallucinogens and atypical antipsychotic drugs at 5-HT 2A and 5-HT 2C...

4‐Aryl‐Substituted 2,5‐Dimethoxyphenethylamines: Synthesis and Serotonin 5‐HT2AReceptor Affinities

Chemistry & Biodiversity May 1, 2009 Daniel Trachsel, David E. Nichols, Stephanie Kidd et al. 15 citations

A series of novel ligands for the serotonin 5-HT(2A/C) receptor subtype bearing the 2-phenylethylamine pharmacophore was synthesized and assayed for its 5-HT(2A) receptor binding affinity. As the 4'-aryl-substituted 2-(2,5-dimethoxyphenyl)ethylamines were previously unknown, an initial series of twelve compounds was chosen to obtain initial insight into their structure-activity relationships....

Brain serotonin transporter binding in former users of MDMA (‘ecstasy’)

The British Journal of Psychiatry March 31, 2009 Sudhakar Selvaraj, Rosa Hoshi, Zubin Bhagwagar et al. 59 citations

Background Animal experimental studies have prompted concerns that widespread use of 3,4-methylenedioxymethamphetamine (MDMA; ‘ecstasy’) by young people may pose a major public health problem in terms of persistent serotonin neurotoxicity. Aims To determine the status of brain serotonin neurons in a group of abstinent MDMA users. Method We assessed the integrity of brain serotonin neurons by...